FULL PAPER
NMR (300 MHz, CDCl3, 298 K): δ = 1.98 (m, 4 H, 2-H and 3-H), C20H32N4O8NaZr+ 569.1159 [ZrL4 + Na]+; found 569.1282; calcd.
3
+
4.03 (br. d, J = 4.8 Hz, 2 H, 6-H), 4.84 (dq, 1 H, 5-Ht), 4.89 (br. for C40H64N8O16NaZr2 1115.2427 [Zr2L8
+
Na]+; found
s, 1 H, 5-Hc), 5.12 (dq, 1 H, 8-Ht), 5.19 (dq, 1 H, 8-Hc), 5.58 (m,
1 H, 4-H), 5.77 (m, 1 H, 7-H), 7.33 (br. s, 15 H, H–Ar) ppm. 13C
NMR (75 MHz, CDCl3, 298 K): δ = 28.5, 32.1, 50.6, 93.6, 114.8,
117.5, 127.8, 128.2, 129.9, 132.6, 137.6, 142.3, 176.5 ppm. HRMS
(ESI): m/z calcd. for C27H27NO2Na+ 420.1934 [M + Na]+; found
420.2055.
1115.2422. C20H32N4O8Zr·0.75H2O (561.26): calcd. C 42.80, H
6.02, N 9.98; found C 43.06, H 6.48, N 9.18.
Tetrakis(1-oxypiperidine-2-one)hafnium(IV) [Hf(1)4]: A solution of
[Hf(acac)4] (0.117 g, 0.203 mmol) in MeOH (50 mL) was added to
a solution of 1H (0.094 g, 0.816 mmol) in MeOH (50 mL). After
stirring the reaction mixture overnight at room temperature, the
solvent was removed under reduced pressure. The crude solid mate-
rial was crystallized from CH2Cl2/heptane (1:1, v/v) to afford
[Hf(1)4] as a colorless solid in 59% yield (0.077 g), m.p. 264 °C
1-(Trityloxy)-3,4-dihydro-1H-azepin-2(7H)-one (11): A mixture of
10 (2.75 g, 6.93 mmol) and Grubbs II catalyst (0.315 g,
0.371 mmol) was dissolved in CH2Cl2 (230 mL) and heated under
reflux conditions for 12 h. The dark red solid material obtained
upon solvent removal was purified by flash column chromatog-
raphy (silica gel, pentane/EtOAc, 1:0 to 3:2 v/v) to afford a reddish
solid product (1.877 g) in 73% yield. A small portion was recrys-
tallized (pentane/EtOAc, 3:2 v/v) to give X-ray-quality crystals,
(decomp.). IR (ATR): ν = 3389 (br., w), 2962 (w), 1612 (s, νC=O),
˜
1481 (s), 1161 (w), 933 (m), 727 (m), 526 (s) cm–1. 1H NMR
(600 MHz, CDCl3, 300 K): δ = 1.70 (m, 2 H, 3-H), 1.82 (m, 2 H,
3
3
4-H), 2.42 (t, J = 6.0 Hz, 2 H, 2-H), 3.57 (t, J = 6.0 Hz, 2 H, 5-
H) ppm. 13C NMR (150 MHz, CDCl3, 300 K): δ = 20.3 (C-3), 23.2
(C-4), 28.8 (C-2), 50.9 (C-5), 161.9 (C-1) ppm. HRMS (ESI): m/z
calcd. for C15H24N3O6Hf+ 522.1125 [HfL3]+; found 522.1131;
calcd. for C20H32N4O8HfNa+ 659.1581 [HfL4 + Na]+; found
m.p. 145.6–146.8 °C. IR (ATR): ν = 3063 (br., w), 1678 (m, νC=O),
˜
1444 (m), 1232 (m), 774 (m), 755 (s), 703 (s), 635 (m) cm–1. 1H
NMR (300 MHz, CDCl3, 298 K): δ = 2.06 (m, 2 H, 3-H), 2.32 (q,
2 H, 2-H), 4.04 (m, 2 H, 6-H), 5.44 (m, 1 H, 5-H), 5.64 (m, 1 H,
4-H), 7.27–7.33 (m, 9 H, 12-H, 13-H), 7.44–7.50 (m, 6 H, 11-H)
ppm. 13C NMR (75 MHz, CDCl3, 298 K): δ = 24.5, 33.0, 51.8,
93.9, 122.8, 127.4, 127.8, 130.2, 131.3, 142.9, 173.3 ppm. HRMS
(ESI): m/z calcd. for C25H23NO2Na+ 392.1621 [M + Na]+; found
392.1619. C25H23NO2 (369.46): calcd. C 81.27, H 6.27, N 3.79;
found C 81.01, H 6.80, N 3.96.
659.1585; calcd. for C40H64N8O16Hf2Na+ 1293.3264 [Hf2L8
+
Na]+; found 1293.3259. C20H32HfN4O8 (634.98): calcd. C 37.83, H
5.08, N 8.82; found C 38.46, H 5.54, N 8.24.
Tetrakis(1-oxypiperidine-2-one)cerium(IV) [Ce(1)4]: A solution of
[Ce(acac)4] (0.100 g, 0.186 mmol) in MeOH (50 mL) was added to
a solution of 1H (0.079 g, 0.686 mmol) in MeOH (50 mL). After
stirring the reaction mixture overnight at room temperature, the
solvent was removed under reduced pressure. The crude solid mate-
rial was crystallized from CH2Cl2/heptane (1:1, v/v) to afford
[Ce(1)4] as a reddish solid in 50% yield (0.055 g), m.p. 189 °C (de-
1-Hydroxy-3,4-dihydro-1H-azepin-2(7H)-one (6H). Method A: A
solution of 11 (1.370 g, 3.71 mmol) in CH2Cl2/MeOH (3:1 v/v;
40 mL) was stirred with BF3·OEt2 (1 mL, 7.42 mmol) for 2 h at
room temperature. After removing the solvent by rotary evapora-
tion, the crude product was purified by flash column chromatog-
raphy (silica gel, CH2Cl2/MeOH, 96:4 v/v) to give 0.210 g of an
orange sticky solid in 44% yield. Method B: A solution of 11
(0.893 g, 2.42 mmol) in CH2Cl2/MeOH (3:2 v/v; 50 mL) was treated
with trifluoroacetic acid (TFA; 0.20 mL, 2.66 mmol), and the reac-
tion mixture was stirred for 6 h at room temperature. Purification
by chromatography as described above afforded 6H in 24% yield
(0.073 g). Colorless crystals of 6H (0.045 g, 10% yield) were ob-
tained by sublimation (45 °C, 2ϫ10–4 mbar), m.p. 184–185 °C. IR
comp.). IR (ATR): ν = 3550 (br., w), 2945 (w), 1587 (s, νC=O), 1471
˜
(s), 1347 (m), 1106 (m), 925 (m), 875 (m), 823 (m), 720 (m), 495 (s)
cm–1. 1H NMR (600 MHz, CDCl3, 300 K): δ = 1.72 (m, 2 H, 3-
3
3
H), 1.80 (m, 2 H, 4-H), 2.44 (t, J = 6.0 Hz, 2 H, 2-H), 3.51 (t, J
= 6.0 Hz, 2 H, 5-H) ppm. 13C NMR (150 MHz, CDCl3, 300 K): δ
= 20.4 (C-3), 23.2 (C-4), 29.6 (C-2), 51.7 (C-5), 163.6 (C-1) ppm.
HRMS (ESI): m/z calcd. for C15H24N4O8Ce+ 482.0719 [CeL3]+;
found 482.0706; calcd. for C20H32N4O8CeNa+ 619.1167 [CeL4
+
Na]+; found 619.1156. C20H32CeN4O8·0.4CH2Cl2 (630.93): calcd.
C 38.07, H 5.24, N 8.88; found C 38.32, H 5.41, N 7.77.
(ATR): ν = 3197 (br., w), 2887 (w), 1655 (br. s, νC=O), 1447 (s),
˜
Tetrakis(1-oxypiperidine-2-one)thorium(IV) [Th(1)4]:
A Schlenk
1162 (s), 897 (m), 784 (s), 645 (br., s), 511 (s), 435 (m) cm–1. 1H
NMR (600 MHz, CDCl3, 300 K): δ = 2.38 (m, 2 H, 3-H), 2.68 (t,
2 H, 2-H), 4.29 (m, 2 H, 6-H), 5.71 (m, 1 H, 5-H), 5.84 (m, 1 H,
4-H) ppm. 13C NMR (150 MHz, CDCl3, 300 K): δ = 24.1 (C-3),
31.6 (C-2), 48.8 (C-6), 122.3 (C-5), 131.0 (C-4), 169.6 (C-1) ppm.
HRMS (ESI): m/z calcd. for C6H10NO2+ 128.0701 [M + H]+; found
128.07061; calcd. for C6H9NO2Na+ 150.0526 [M + Na]+; found
150.0520.
tube was charged with [ThN*2(N,C)] (20 mg, 0.028 mmol), 1H
(12.9 mg, 0.112 mmol), and pyridine (ca. 1 mL). After 2 h at 90 °C,
the colorless solution was concentrated to 0.5 mL, and pentane
(2 mL) was condensed into the solution, thus leading to a white
deposit that was filtered off and dried under vacuum for 1 h, yield
15.1 mg (78%). Colorless crystals of [Th(1)4] were formed upon
slow diffusion of pentane into a solution of pyridine. IR (Nujol
mull): ν = 1607 (vs, νC=O), 925, 722 cm–1. 1H NMR (200 MHz, [D5]
˜
pyridine, 296 K): δ = 1.25 (s, 2 H, 3-H), 1.34 (s, 2 H, 4-H), 2.14 (s, 2
H, 2-H), 3.52 (s, 2 H, 5-H) ppm. 13C NMR (50 MHz, [D5]pyridine,
296 K): δ = 21.5 (C-3), 24.2 (C-4), 31.5 (C-2), 52.8 (C-5), 162.4 (C-
1) ppm.
Tetrakis(1-oxypiperidine-2-one)zirconium(IV) [Zr(1)4]: A solution of
[Zr(acac)4] (0.419 g, 0.859 mmol) in MeOH (50 mL) was added
with a cannula to a solution that contained 4 equiv. of 1H (0.398 g,
3.46 mmol) in MeOH (150 mL). After stirring overnight, the sol-
vent was removed under reduced pressure to afford a crude mate-
Tetrakis(1-oxypiperidine-2-one)uranium(IV) [U(1)4]: An NMR spec-
rial that was recrystallized from CH2Cl2/heptane (1:1, v/v). Pure troscopy tube was charged with [UN*2(N,C)] (20 mg, 0.028 mmol),
[Zr(1)4] was isolated as a colorless solid in 57% yield (0.269 g), m.p. 1H (12.8 mg, 0.111 mmol), and pyridine (ca. 1 mL). The solution
194–195 °C. IR (ATR): ν = 3400 (br., w), 2958 (w), 1608 (s, νC=O), became blue-gray immediately and the mixture was heated at 90 °C
˜
1480 (s), 931 (w), 727 (m), 520 (s) cm–1. 1H NMR (600 MHz, for 30 min. Et2O (2 mL) was then condensed into the solution to
CDCl3, 300 K): δ = 1.71 (m, 2 H, 3-H), 1.83 (m, 2 H, 4-H), 2.44 give a blue-green deposit of [U(1)4], which was filtered off, washed
(t, 3J = 6 Hz, 2 H, 2-H), 3.58 (t, 3J = 6 Hz, 2 H, 5-H) ppm. 13C
with Et2O (2 mL), and then dried under vacuum for 3 h, yield
NMR (150 MHz, CDCl3, 300 K): δ = 20.2 (C-3), 23.1 (C-4), 28.6 17.4 mg (90%). Large pale green crystals of [U(1)4], the color of
(C-2), 50.7 (C-5), 161.9 (C-1) ppm. HRMS (ESI): m/z calcd. for which also appeared purple depending on the orientation of the
C15H24N3O6Zr+ 432.0707 [ZrL3]+; found 432.0759; calcd. for
crystals and lighting, were formed upon slow diffusion of pentane
Eur. J. Inorg. Chem. 2015, 1529–1541
1539 © 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim